The global liver diseases therapeutics market is expected to grow from USD 11.10 billion in 2019 to USD 20.86 billion by 2027, at a CAGR of 8.2% during the forecast period 2020-2027.
Liver disease has a broad range of complex conditions which affects the liver. The liver diseases therapeutics market is driven by untapped requirements of patients as well as liver diseases such as hepatocellular carcinoma. Further, increased geriatric population is contributing to the growth of the market over the forecast period. Increased research and development activities by biotechnology and pharmaceutical companies are driving the growth of the market. Moreover, the presence of a robust pipeline is also generating higher demand. Vaccination programs initiated by the major companies and governments are also driving the growth of the market. People are aware in order to maintain health to prevent such diseases.
This study delivers a comprehensive analysis of products, end-users and regions. The product segment includes corticosteroids, immunoglobulins, targeted therapy, chemotherapy, immunosuppressants, vaccines and antiviral drugs. Antiviral drugs segment has the highest growth in the market. A rise in the prevalence of liver diseases, consumption of alcohol and population are contributing factors in the growth of the market. The market growth is attributed primarily due to new product launches. Victrelis and Incivek are the latest products as well as ThermoDox and GS-7977 are a strong pipeline of drugs for the treatment of liver diseases. The end-user segment includes ambulatory surgery centres, hospitals and specialty clinics. Hospital segment has the highest growth in the market. The growth of the hospital segment is due to an increased number of patients admitted to hospitals for the liver disease therapeutics along with a rise in the prevalence of liver diseases. Hospitals play an important role in health insurance reimbursement. Hence, it is highly preferred in developed economies.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America has the largest share in the liver diseases therapeutics market. It is due to an increased awareness among patients regarding new and advanced products which targets the unmet medical requirements. Also, presence of academic and research institutes in the region which conducts clinical trial studies are contributing to the growth of the market.
Some of the notable players in the liver diseases therapeutics market are Astellas Pharma Inc., Gilead Sciences, F. Hoffmann-La Roche Ltd., Novartis AG, Takeda Pharmaceuticals, Watson Pharmaceuticals, Abbott Laboratories, GlaxoSmithKline plc, Sanofi S.A., Valeant Pharmaceuticals, Merck & Co., Inc., Pfizer Inc and Bristol-Mayers Squibb. Key companies are focusing more on investing a massive amount of money in research and development activities in order to develop advanced and innovative treatment for liver diseases. Companies are also emphasizing on no side effects and high efficient pharmaceutical drugs in order to expand the market base.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Liver Diseases Therapeutics Market Analysis And Forecast, By Product
Global Liver Diseases Therapeutics Market Analysis And Forecast, By End-User
Global Liver Diseases Therapeutics Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Product
4.3.2. Market Attractiveness Analysis By End-User
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Opportunities
5.5. Challenges
6. Global Liver Diseases Therapeutics Market Analysis and Forecast, By Product
6.1. Segment Overview
6.2. Corticosteroids,
6.3. Immunoglobulins
6.4. Targeted Therapy
6.5. Chemotherapy
6.6. Immunosuppressants
6.7. Vaccines
6.8. Antiviral Drugs
7. Global Liver Diseases Therapeutics Market Analysis and Forecast, By End-User
7.1. Segment Overview
7.2. Ambulatory Surgery Centers
7.3. Hospitals
7.4. Specialty Clinics
8. Global Liver Diseases Therapeutics Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Liver Diseases Therapeutics Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Liver Diseases Therapeutics Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Astellas Pharma Inc
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Gilead Sciences
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. F. Hoffmann-La Roche Ltd
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Novartis AG
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Takeda Pharmaceuticals
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Watson Pharmaceuticals
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Abbott Laboratories
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. GlaxoSmithKline plc
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Sanofi S.A
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Valeant Pharmaceuticals
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. Merck & Co., Inc
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Product Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. Pfizer Inc
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Product Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Bristol-Mayers Squibb
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Product Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
List of Table
1. Global Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
2. Global Corticosteroids, Market, By Region, 2017–2027(USD Billion)
3. Global Immunoglobulins, By Region, 2017–2027(USD Billion)
4. Global Targeted Therapy Market, By Region, 2017–2027(USD Billion)
5. Global Chemotherapy Market, By Region, 2017–2027(USD Billion)
6. Global Immunosuppressants Market, By Region, 2017–2027(USD Billion)
7. Global Vaccines Market, By Region, 2017–2027(USD Billion)
8. Global Antiviral Drugs Market, By Region, 2017–2027(USD Billion)
9. Global Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
10. Global Ambulatory Surgery Centers Liver Diseases Therapeutics Market, By Region, 2017–2027(USD Billion)
11. Global Hospitals Ingredient Market, By Region, 2017–2027(USD Billion)
12. Global Specialty Clinics Ingredient Market, By Region, 2017–2027(USD Billion)
13. Global Liver Diseases Therapeutics Market, By North America, 2017–2027(USD Billion)
14. North America Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
15. North America Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
16. U.S. Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
17. U.S. Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
18. Canada Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
19. Canada Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
20. Mexico Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
21. Mexico Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
22. Europe Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
23. Europe Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
24. Germany Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
25. Germany Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
26. France Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
27. France Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
28. U.K. Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
29. U.K. Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
30. Italy Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
31. Italy Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
32. Spain Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
33. Spain Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
34. Asia Pacific Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
35. Asia Pacific Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
36. Japan Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
37. Japan Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
38. China Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
39. China Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
40. India Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
41. India Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
42. South America Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
43. South America Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
44. Brazil Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
45. Brazil Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
46. Middle East and Africa Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
47. Middle East and Africa Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
48. UAE Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
49. UAE Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
50. South Africa Liver Diseases Therapeutics Market, By Product, 2017–2027(USD Billion)
51. South Africa Liver Diseases Therapeutics Market, By End-User, 2017–2027(USD Billion)
List of Figures
1. Global Liver Diseases Therapeutics Market Segmentation
2. Liver Diseases Therapeutics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Liver Diseases Therapeutics Market Attractiveness Analysis By Product
9. Global Liver Diseases Therapeutics Market Attractiveness Analysis By End-User
10. Global Liver Diseases Therapeutics Market Attractiveness Analysis By Region
11. Global Liver Diseases Therapeutics Market: Dynamics
12. Global Liver Diseases Therapeutics Market Share By Product (2019 & 2027)
13. Global Liver Diseases Therapeutics Market Share By End-User (2019 & 2027)
14. Global Liver Diseases Therapeutics Market Share by Regions (2019 & 2027)
15. Global Liver Diseases Therapeutics Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.